We help you join the dots...

RAS LSS is a niche strategy consultancy serving the global life sciences sector

 
 

Starting with Information Services in 2014, RAS LSS has evolved into a boutique healthcare consulting group. We offer a niche portfolio of Strategy Support and Information Services to Pharmaceutical and Medical Device Companies, throughout the product life-cycle.

We elucidate and contextualize current and future market complexities. Leveraging our collective intelligence, we strive to help our clients succeed via

  • Best In Class Situation Analysis
  • Competitively Differentiated Strategy
With an outreach across mature and emerging markets, we go the extra mile to create fresh perspectives for our clients in their mission to reduce the global burden of disease.


We have put in the hours and the sweat to be credible…



Latest Blogs

July 23, 2019
RNA

Biology’s Central Dogma Has Been Overturned! So What?

In August 2018, patisiran, a first-in-class therapy was approved in the US and EU to treat the polyneuropathy associated with a genetic disease 002D hereditary transthyretin-mediated amyloidosis. The therapy uses small pieces of ribonucleic acid (RNA) to effectively ‘silence’ a faulty gene, without changing the deoxy ribonucleic acid (DNA) of […]
July 19, 2019
Repurposing

Old wine in a new bottle? Introduction to Drug Repurposing

Translating a discovery in biology to a marketable medical breakthrough is a long drawn, tedious, high-investment, and high-risk process. Drug repurposing / repositioning has turned into a popular strategy of late. Not quite the same as traditional drug development techniques, the strategy is productive, affordable and is associated with reduced […]
July 18, 2019
marijuna

From ‘Weed rush’ to a ‘Pot of Gold’ – Medical Marijuana and the Pharma Industry

    The story back then… Cannabis’ (Marijuana) use as medicine dates back to 4000 BC in China. During the 19th century and till early 20th century, marijuana was used globally, to treat various illnesses such as migraine, neuropathic pain, musculoskeletal pain and in childbirth.2 In Canada, cannabis was added […]
July 18, 2019
value-based care

Healthcare: Shift from Volume to Value

Healthcare is an expanding and complex industry. The ageing population, higher prevalence of chronic diseases, advances in digital technologies, highly efficacious and expensive drugs have led to an increase in the healthcare demand and expenditures. The global health care spending projected at $ 10.05 Trillion by 2022 represents 2018-2022 CAGR […]
July 12, 2019
Brexit

Deal or No Deal Brexit? – What’s Next for the Pharmaceutical Industry

It’s been almost 3 years since the British voted 52-48% to leave the EU on 23rd June 2016.12  Given the lack of clarity and ensuing uncertainty, the pharmaceutical companies have been planning for a worst-case scenario i.e. no-deal. We will look at the most important (subjectively assessed) implications of a […]
July 10, 2019
3D Printing

Body Printing or Printing Your Body: A Short Introduction To Bioprinting

Biofabrication can be defined as the production of complex living and non-living biological products from raw materials such as living cells, molecules, extracellular matrices, and biomaterials. – Mironov et al., 2015. First things first…What´s 3D printing? The standard two-dimensional (2D) printing is the act of depositing ink on a 2D […]